NASDAQ:NVCN - Neovasc Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.03 0.00 (0.00 %)
(As of 05/22/2018 12:01 PM ET)
Previous Close$0.03
Today's Range$0.03 - $0.03
52-Week Range$0.03 - $1.89
Volume495,152 shs
Average Volume88.59 million shs
Market Capitalization$52.62 million
P/E Ratio-0.10
Dividend YieldN/A
Beta1.24

About Neovasc (NASDAQ:NVCN)

Neovasc logoNeovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Receive NVCN News and Ratings via Email

Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NVCN
CUSIPN/A
Phone604-270-4344

Debt

Debt-to-Equity Ratio-0.73
Current Ratio0.92
Quick Ratio0.90

Price-To-Earnings

Trailing P/E Ratio-0.10
Forward P/E Ratio-0.33
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.39 million
Price / Sales9.36
Cash FlowN/A
Price / CashN/A
Book Value($0.46) per share
Price / Book-0.07

Profitability

EPS (Most Recent Fiscal Year)($0.37)
Net Income$-22,900,000.00
Net Margins-1,687.90%
Return on Equity-85.81%
Return on Assets-52.15%

Miscellaneous

Employees147
Outstanding Shares1,681,060,000

Neovasc (NASDAQ:NVCN) Frequently Asked Questions

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

How were Neovasc's earnings last quarter?

Neovasc Inc. (NASDAQ:NVCN) released its quarterly earnings results on Wednesday, March, 28th. The medical equipment provider reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.01. The medical equipment provider had revenue of $1.23 million for the quarter, compared to analysts' expectations of $1.18 million. Neovasc had a negative return on equity of 85.81% and a negative net margin of 1,687.90%. View Neovasc's Earnings History.

When is Neovasc's next earnings date?

Neovasc is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for Neovasc.

What price target have analysts set for NVCN?

2 brokerages have issued 12-month price targets for Neovasc's stock. Their predictions range from $0.50 to $2.00. On average, they anticipate Neovasc's share price to reach $1.25 in the next twelve months. View Analyst Ratings for Neovasc.

Are investors shorting Neovasc?

Neovasc saw a increase in short interest during the month of April. As of April 30th, there was short interest totalling 74,020,430 shares, an increase of 55.3% from the April 13th total of 47,655,636 shares. Based on an average daily trading volume, of 87,826,510 shares, the days-to-cover ratio is presently 0.8 days. Currently, 83.5% of the shares of the stock are short sold.

Who are some of Neovasc's key competitors?

Who are Neovasc's key executives?

Neovasc's management team includes the folowing people:
  • Mr. Christopher Clark, CFO & Corp. Sec. (Age 46)
  • Mr. Brian McPherson, Chief Operating Officer (Age 56)
  • Ms. Vicki Bebeau, VP of Clinical and Regulatory Affairs
  • Mr. Randy Lane, VP of R&D
  • Mr. Alexei J. Marko, Advisor & Director (Age 49)

Has Neovasc been receiving favorable news coverage?

Media headlines about NVCN stock have trended somewhat positive recently, according to Accern. The research firm ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Neovasc earned a media sentiment score of 0.18 on Accern's scale. They also assigned news headlines about the medical equipment provider an impact score of 45.49 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Neovasc's major shareholders?

Neovasc's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Gagnon Securities LLC (0.35%). View Institutional Ownership Trends for Neovasc.

Which institutional investors are buying Neovasc stock?

NVCN stock was acquired by a variety of institutional investors in the last quarter, including Gagnon Securities LLC. View Insider Buying and Selling for Neovasc.

How do I buy shares of Neovasc?

Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $0.03.

How big of a company is Neovasc?

Neovasc has a market capitalization of $52.62 million and generates $5.39 million in revenue each year. The medical equipment provider earns $-22,900,000.00 in net income (profit) each year or ($0.37) on an earnings per share basis. Neovasc employs 147 workers across the globe.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, Richmond A1, V6V 2J7. The medical equipment provider can be reached via phone at 604-270-4344 or via email at [email protected]


MarketBeat Community Rating for Neovasc (NVCN)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  192 (Vote Outperform)
Underperform Votes:  161 (Vote Underperform)
Total Votes:  353
MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVCN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVCN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Neovasc (NASDAQ:NVCN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Neovasc in the last 12 months. Their average twelve-month price target is $1.25, suggesting that the stock has a possible upside of 4,066.67%. The high price target for NVCN is $2.00 and the low price target for NVCN is $0.50. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.25$1.25$3.35$6.3333
Price Target Upside: 4,066.67% upside1,983.33% upside544.23% upside313.94% upside

Neovasc (NASDAQ:NVCN) Consensus Price Target History

Price Target History for Neovasc (NASDAQ:NVCN)

Neovasc (NASDAQ:NVCN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/29/2018Canaccord GenuityLower Price TargetBuy ➝ Buy$1.05 ➝ $0.50LowView Rating Details
3/29/2018Leerink SwannLower Price TargetOutperform ➝ Outperform$5.00 ➝ $2.00HighView Rating Details
4/5/2017Ladenburg ThalmannUpgradeNeutral ➝ Buy$4.00HighView Rating Details
4/3/2017JMP SecuritiesReiterated RatingOutperform$5.00MediumView Rating Details
(Data available from 5/22/2016 forward)

Earnings

Neovasc (NASDAQ:NVCN) Earnings History and Estimates Chart

Earnings by Quarter for Neovasc (NASDAQ:NVCN)

Neovasc (NASDAQ:NVCN) Earnings Estimates

2018 EPS Consensus Estimate: $0.00
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.00$0.00$0.00
Q2 20181$0.00$0.00$0.00
Q3 20181$0.00$0.00$0.00
Q4 20181$0.00$0.00$0.00

Neovasc (NASDAQ NVCN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2018        
3/28/2018Q4 2017($0.01)($0.02)$1.18 million$1.23 millionViewN/AView Earnings Details
11/14/2017Q3 2017($0.02)($0.06)$1.42 million$1.38 millionViewN/AView Earnings Details
8/10/20176/30/2017($0.02)($0.04)$1.40 million$1.31 millionViewN/AView Earnings Details
5/10/2017Q1 2017($0.08)($0.10)$3.90 million$1.48 millionViewN/AView Earnings Details
3/23/2017Q4 2016$0.47$3.00 million$2.76 millionViewN/AView Earnings Details
11/14/2016Q216($0.06)($0.12)$2.20 million$3.03 millionViewN/AView Earnings Details
8/9/2016Q2 2016($0.09)($0.20)$3.20 million$1.71 millionViewN/AView Earnings Details
4/29/2016Q1 2016($0.10)($0.10)$3.10 million$2.01 millionViewN/AView Earnings Details
3/29/2016Q415($0.15)($0.11)$3.26 million$2.24 millionViewN/AView Earnings Details
11/9/2015Q3 2015($0.10)($0.11)$3.46 million$2.48 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.10)($0.10)$3.19 million$2.93 millionViewN/AView Earnings Details
5/12/2015Q115($0.05)($0.08)$3.84 million$2.86 millionViewN/AView Earnings Details
3/30/2015Q414($0.06)($0.11)$3.31 million$3.35 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.08)$3.77 millionViewN/AView Earnings Details
8/13/2014Q2 2014($0.11)$4.03 millionViewN/AView Earnings Details
5/22/2014Q1 2014($0.01)$3.48 millionViewN/AView Earnings Details
4/17/2014Q4 2013($0.04)$3.22 millionViewN/AView Earnings Details
11/20/2013Q3 2013($0.03)$3.50 millionViewN/AView Earnings Details
8/15/2013Q2 2013($0.03)$2.73 millionViewN/AView Earnings Details
5/28/2013Q1 2013($0.04)$2.00 millionViewN/AView Earnings Details
4/29/2013Q4 2012($0.02)ViewN/AView Earnings Details
11/26/2012Q3 2012($0.03)ViewN/AView Earnings Details
8/9/2012Q2 2012($0.03)ViewN/AView Earnings Details
5/29/2012Q1 2012($0.03)ViewN/AView Earnings Details
4/25/2012Q4 2011($0.02)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Neovasc (NASDAQ:NVCN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Neovasc (NASDAQ NVCN) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 2.41%
Insider Trading History for Neovasc (NASDAQ:NVCN)
Institutional Ownership by Quarter for Neovasc (NASDAQ:NVCN)

Neovasc (NASDAQ NVCN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Neovasc (NASDAQ NVCN) News Headlines

Source:
DateHeadline
Should you buy stock in Apple, Macys, Micron, Netflix or Neovasc Inc?Should you buy stock in Apple, Macy's, Micron, Netflix or Neovasc Inc?
www.prnewswire.com - May 16 at 10:25 AM
Neovasc (NVCN) Urges Shareholders to Vote In Favor of Proposed Reverse Stock SplitNeovasc (NVCN) Urges Shareholders to Vote In Favor of Proposed Reverse Stock Split
www.streetinsider.com - May 15 at 4:13 PM
Neovascs Management and Board of Directors Urge Shareholders to Vote In Favor of the Proposed Reverse Stock ...Neovasc's Management and Board of Directors Urge Shareholders to Vote In Favor of the Proposed Reverse Stock ...
www.prnewswire.com - May 15 at 10:31 AM
BRIEF-Neovascs Management And Board Of Directors Urge Shareholders To Vote In Favor Of The Proposed Reverse ...BRIEF-Neovasc's Management And Board Of Directors Urge Shareholders To Vote In Favor Of The Proposed Reverse ...
www.reuters.com - May 15 at 10:31 AM
Neovascs Management and Board of Directors Urge Shareholders to Vote In Favor of the Proposed Reverse Stock Split at the Upcoming Annual General and Special Meeting of ShareholdersNeovasc's Management and Board of Directors Urge Shareholders to Vote In Favor of the Proposed Reverse Stock Split at the Upcoming Annual General and Special Meeting of Shareholders
finance.yahoo.com - May 15 at 10:31 AM
BRIEF-Neovasc Qtrly Operating Losses $6.5 MillionBRIEF-Neovasc Qtrly Operating Losses $6.5 Million
www.reuters.com - May 11 at 11:06 AM
Neovasc Announces Results for the First Quarter 2018Neovasc Announces Results for the First Quarter 2018
www.prnewswire.com - May 11 at 11:06 AM
Neovascs (NVCN) CEO Fred Colen on Q1 2018 Results - Earnings Call TranscriptNeovasc's (NVCN) CEO Fred Colen on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 11:06 AM
Neovasc Inc. (NVCN) Short Interest Up 55.3% in AprilNeovasc Inc. (NVCN) Short Interest Up 55.3% in April
www.americanbankingnews.com - May 11 at 3:06 AM
Cantel Medical (CMD) and Neovasc (NVCN) Head-To-Head SurveyCantel Medical (CMD) and Neovasc (NVCN) Head-To-Head Survey
www.americanbankingnews.com - May 10 at 5:24 PM
Neovasc (NVCN) Reports Compliance with Nasdaq Minimum Market Value RuleNeovasc (NVCN) Reports Compliance with Nasdaq Minimum Market Value Rule
www.streetinsider.com - May 10 at 4:03 PM
Neovasc Regains Compliance with Nasdaq Minimum Market Value RuleNeovasc Regains Compliance with Nasdaq Minimum Market Value Rule
finance.yahoo.com - May 10 at 4:03 PM
Neovasc (NVCN) Upgraded by ValuEngine to "Sell"Neovasc (NVCN) Upgraded by ValuEngine to "Sell"
www.americanbankingnews.com - May 2 at 11:11 PM
Neovasc Provides a General Update, Announces Filing of Annual Report on Form 20-F and Sets First Quarter 2018 ...Neovasc Provides a General Update, Announces Filing of Annual Report on Form 20-F and Sets First Quarter 2018 ...
www.prnewswire.com - May 1 at 9:50 AM
Neovasc Provides a General Update, Announces Filing of Annual Report on Form 20-F and Sets First Quarter 2018 Financial Results Conference Call and WebcastNeovasc Provides a General Update, Announces Filing of Annual Report on Form 20-F and Sets First Quarter 2018 Financial Results Conference Call and Webcast
finance.yahoo.com - May 1 at 9:50 AM
Neovasc (NVCN) vs. Alliqua BioMedical (ALQA) Head to Head SurveyNeovasc (NVCN) vs. Alliqua BioMedical (ALQA) Head to Head Survey
www.americanbankingnews.com - April 30 at 11:23 AM
Short Interest in Neovasc Inc. (NVCN) Rises By 365.9%Short Interest in Neovasc Inc. (NVCN) Rises By 365.9%
www.americanbankingnews.com - April 26 at 1:14 AM
Neovasc (NVCN) Announces Receipt of US$7.1 Million from Exercise of Series C WarrantsNeovasc (NVCN) Announces Receipt of US$7.1 Million from Exercise of Series C Warrants
www.streetinsider.com - April 12 at 10:52 AM
Neovasc Announces Receipt of US$7.1 Million from Exercise of Series C WarrantsNeovasc Announces Receipt of US$7.1 Million from Exercise of Series C Warrants
finance.yahoo.com - April 12 at 10:52 AM
Neovasc Inc (US) (NVCN) Short Interest Up 121.3% in MarchNeovasc Inc (US) (NVCN) Short Interest Up 121.3% in March
www.americanbankingnews.com - April 12 at 1:09 AM
What Should We Expect From Neovasc Inc’s (NASDAQ:NVCN) Earnings In The Years Ahead?What Should We Expect From Neovasc Inc’s (NASDAQ:NVCN) Earnings In The Years Ahead?
finance.yahoo.com - April 11 at 10:44 AM
Neovasc Inc (US) (NVCN) Downgraded by Zacks Investment Research to "Sell"Neovasc Inc (US) (NVCN) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - April 10 at 9:44 AM
Neovasc Inc (US) (NVCN) Cut to "Hold" at Zacks Investment ResearchNeovasc Inc (US) (NVCN) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 6 at 6:29 PM
Today’s Research Reports on Trending Tickers: AVEO Pharmaceuticals and NeovascToday’s Research Reports on Trending Tickers: AVEO Pharmaceuticals and Neovasc
finance.yahoo.com - April 6 at 10:36 AM
Neovasc Inc (US) (NVCN) Stock Rating Lowered by Zacks Investment ResearchNeovasc Inc (US) (NVCN) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 5 at 9:35 AM
Was Neovasc Inc’s (NASDAQ:NVCN) Earnings Growth Better Than The Industry’s?Was Neovasc Inc’s (NASDAQ:NVCN) Earnings Growth Better Than The Industry’s?
finance.yahoo.com - April 1 at 9:59 AM
Neovasc Inc (US) (NVCN) PT Lowered to $0.50 at Canaccord GenuityNeovasc Inc (US) (NVCN) PT Lowered to $0.50 at Canaccord Genuity
www.americanbankingnews.com - March 29 at 2:30 PM
Neovasc Inc (US)s (NVCN) "Outperform" Rating Reaffirmed at Leerink SwannNeovasc Inc (US)'s (NVCN) "Outperform" Rating Reaffirmed at Leerink Swann
www.americanbankingnews.com - March 29 at 12:10 PM
Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017
finance.yahoo.com - March 29 at 10:29 AM
Neovasc Inc. to Host Earnings CallNeovasc Inc. to Host Earnings Call
finance.yahoo.com - March 28 at 3:58 PM
Neovasc Inc (US) (NVCN) Sees Large Growth in Short InterestNeovasc Inc (US) (NVCN) Sees Large Growth in Short Interest
www.americanbankingnews.com - March 28 at 2:02 AM
Neovasc (NVCN) Receives Nasdaq Notification Regarding Minimum Market Value Deficiency - StreetInsider.comNeovasc (NVCN) Receives Nasdaq Notification Regarding Minimum Market Value Deficiency - StreetInsider.com
www.streetinsider.com - March 24 at 8:11 AM
Neovasc Inc (US) (NVCN) to Release Earnings on WednesdayNeovasc Inc (US) (NVCN) to Release Earnings on Wednesday
www.americanbankingnews.com - March 24 at 12:52 AM
Neovasc (NVCN) Receives Nasdaq Notification Regarding Minimum Market Value DeficiencyNeovasc (NVCN) Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
www.streetinsider.com - March 23 at 6:23 PM
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value DeficiencyNeovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
finance.yahoo.com - March 23 at 6:23 PM
Neovasc Announces Year End 2017 Financial Results Conference Call and WebcastNeovasc Announces Year End 2017 Financial Results Conference Call and Webcast
finance.yahoo.com - March 22 at 9:50 AM
Analyzing Neovasc Inc (US) (NVCN) & Danaher (DHR)Analyzing Neovasc Inc (US) (NVCN) & Danaher (DHR)
www.americanbankingnews.com - March 16 at 11:12 PM
Is Neovasc Inc (NASDAQ:NVCN) A Buy At Its Current PE Ratio?Is Neovasc Inc (NASDAQ:NVCN) A Buy At Its Current PE Ratio?
finance.yahoo.com - March 16 at 10:57 AM
Traders News Source: Neovasc, Pipeline Development, Analysts Target Price, Institutional InvestorsTraders News Source: Neovasc, Pipeline Development, Analysts Target Price, Institutional Investors
www.finanznachrichten.de - March 13 at 11:35 AM
Neovasc, Pipeline Development, Analysts Target Price, Institutional InvestorsNeovasc, Pipeline Development, Analysts Target Price, Institutional Investors
finance.yahoo.com - March 13 at 11:35 AM
Neovasc Inc (US) (NVCN) Given Average Recommendation of "Hold" by AnalystsNeovasc Inc (US) (NVCN) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - March 10 at 9:44 AM
Reviewing Illumina (ILMN) and Neovasc Inc (US) (NVCN)Reviewing Illumina (ILMN) and Neovasc Inc (US) (NVCN)
www.americanbankingnews.com - March 10 at 5:12 AM
Neovasc Inc (US) (NVCN) Short Interest Down 37.2% in FebruaryNeovasc Inc (US) (NVCN) Short Interest Down 37.2% in February
www.americanbankingnews.com - March 4 at 1:40 AM
Gagnon Advisors LLC Acquires 610,376 Shares of Neovasc Inc (US) (NVCN)Gagnon Advisors LLC Acquires 610,376 Shares of Neovasc Inc (US) (NVCN)
www.americanbankingnews.com - March 2 at 5:42 PM
Hudson Bay Capital Management LP Buys Shares of 10,355,108 Neovasc Inc (US) (NVCN)Hudson Bay Capital Management LP Buys Shares of 10,355,108 Neovasc Inc (US) (NVCN)
www.americanbankingnews.com - February 28 at 1:47 PM
Neovasc Inc (US) (NVCN) Given Average Rating of "Hold" by AnalystsNeovasc Inc (US) (NVCN) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - February 13 at 9:22 AM
Neovasc to Present at LEERINK Partners 7th Annual Global Healthcare ConferenceNeovasc to Present at LEERINK Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 12 at 3:21 PM
Short Interest in Neovasc Inc (US) (NVCN) Drops By 56.6%Short Interest in Neovasc Inc (US) (NVCN) Drops By 56.6%
www.americanbankingnews.com - February 11 at 1:32 AM
Neovascs Reducer nabs elevated reimbursement status in ... - Seeking AlphaNeovasc's Reducer nabs elevated reimbursement status in ... - Seeking Alpha
seekingalpha.com - February 1 at 3:20 PM
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory AnginaNeovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina
finance.yahoo.com - February 1 at 3:20 PM

SEC Filings

Neovasc (NASDAQ:NVCN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Neovasc (NASDAQ:NVCN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Neovasc (NASDAQ NVCN) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.